Objective 3: Surveillance of AMR and antibiotic usage

Objective Three of the National Antimicrobial Resistance (AMR) Strategy aims to:

  • enhance our capacity to collect, analyse and report on AMR and the use of antimicrobials in Australia
  • provide data on resistant organisms, and the illnesses caused by them, to understand their:
    • magnitude
    • distribution
    • impact
  • inform local, national, regional and global action that needs to take place and evaluate our response to AMR.

Why is this important?

Surveillance collects, analyses and reports data on key organisms that are resistant to antibiotics and on the use of antibiotics. Surveillance improves our how we can respond to the threat of AMR by detecting:

View the full details of Objective Three of the National Antimicrobial Resistance Strategy 2015–2019, including specific priority areas of action.

What are we doing?

  • Australia has a national system for AMR and antibiotic usage surveillance in human health. The system is called the AURA Surveillance System. It collects and reports on data from hospitals, aged care facilities and the community.

The report is primarily focussed on analyses of 2015 data. It builds on AURA 2016 to increase the comprehensiveness of the picture of antimicrobial use, resistance and the appropriateness of prescribing in Australia across all healthcare settings.

Find out more about what partners from across Australia are doing to support Objective Three of the National AMR Strategy.

Share your activity or research project that supports Objective Three of the National AMR Strategy.

Last updated: 
31 October 2017